Nicholas Sicignano

961 total citations
37 papers, 727 citations indexed

About

Nicholas Sicignano is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Internal Medicine. According to data from OpenAlex, Nicholas Sicignano has authored 37 papers receiving a total of 727 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cardiology and Cardiovascular Medicine, 9 papers in Pulmonary and Respiratory Medicine and 9 papers in Internal Medicine. Recurrent topics in Nicholas Sicignano's work include Atrial Fibrillation Management and Outcomes (10 papers), Venous Thromboembolism Diagnosis and Management (9 papers) and Cardiac Arrhythmias and Treatments (4 papers). Nicholas Sicignano is often cited by papers focused on Atrial Fibrillation Management and Outcomes (10 papers), Venous Thromboembolism Diagnosis and Management (9 papers) and Cardiac Arrhythmias and Treatments (4 papers). Nicholas Sicignano collaborates with scholars based in United States, Canada and Switzerland. Nicholas Sicignano's co-authors include Žhong Yuan, Toni Rush, Norman Rosenthal, Jacob A. Udell, Amber Evans, W. Frank Peacock, K Hopf, Manesh R. Patel, W. Michael Pullen and Marlene DeMaio and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Blood.

In The Last Decade

Nicholas Sicignano

32 papers receiving 711 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nicholas Sicignano United States 14 240 205 203 147 124 37 727
Nathalie Trillot France 12 188 0.8× 167 0.8× 505 2.5× 265 1.8× 53 0.4× 35 1.1k
Chang Cl Taiwan 10 266 1.1× 67 0.3× 116 0.6× 288 2.0× 24 0.2× 29 1.0k
Aditya Raju United States 14 106 0.4× 301 1.5× 46 0.2× 64 0.4× 156 1.3× 41 756
Marie‐Hélène Horellou France 15 281 1.2× 104 0.5× 66 0.3× 338 2.3× 18 0.1× 31 787
Ioannis Karalis Netherlands 16 416 1.7× 163 0.8× 54 0.3× 20 0.1× 66 0.5× 42 699
IJ Mackie United Kingdom 13 90 0.4× 149 0.7× 48 0.2× 110 0.7× 21 0.2× 38 577
Carsten Agger Denmark 8 114 0.5× 62 0.3× 192 0.9× 104 0.7× 9 0.1× 9 685
J.-P. Cambou France 11 139 0.6× 176 0.9× 86 0.4× 73 0.5× 45 0.4× 20 633
Leslie Skeith Canada 14 177 0.7× 142 0.7× 15 0.1× 232 1.6× 26 0.2× 66 605
Zekeriya Nurkalem Türkiye 15 396 1.6× 101 0.5× 162 0.8× 41 0.3× 34 0.3× 59 681

Countries citing papers authored by Nicholas Sicignano

Since Specialization
Citations

This map shows the geographic impact of Nicholas Sicignano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas Sicignano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas Sicignano more than expected).

Fields of papers citing papers by Nicholas Sicignano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicholas Sicignano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas Sicignano. The network helps show where Nicholas Sicignano may publish in the future.

Co-authorship network of co-authors of Nicholas Sicignano

This figure shows the co-authorship network connecting the top 25 collaborators of Nicholas Sicignano. A scholar is included among the top collaborators of Nicholas Sicignano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicholas Sicignano. Nicholas Sicignano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Hillert, Jan, Helmut Butzkueven, Melinda Magyari, et al.. (2024). Harmonized Data Quality Indicators Maintain Data Quality in Long-Term Safety Studies Using Multiple Sclerosis Registries/Data Sources: Experience from the CLARION Study. Clinical Epidemiology. Volume 16. 717–732. 2 indexed citations
3.
Rush, Toni, et al.. (2023). The Military Health System: Minimizing Disparities in Breast Cancer Treatment. Military Medicine. 188(Supplement_6). 494–502.
4.
Goehring, Earl, Rhonda L. Bohn, John C. Pezzullo, et al.. (2020). Outcomes Associated with Dronedarone Use in Patients with Atrial Fibrillation. The American Journal of Cardiology. 135. 77–83. 8 indexed citations
5.
Udell, Jacob A., et al.. (2019). CARDIOVASCULAR OUTCOMES AND MORTALITY AFTER INITIATION OF CANAGLIFLOZIN VERSUS NON-SGLT2I ANTIHYPERGLYCEMIC AGENTS: ADDITIONAL ANALYSES FROM THE EASEL POPULATION-BASED COHORT STUDY. Journal of the American College of Cardiology. 73(9). 1780–1780. 2 indexed citations
6.
Rush, Toni, et al.. (2018). A plateau in new onset type 1 diabetes: Incidence of pediatric diabetes in the United States Military Health System. Pediatric Diabetes. 19(5). 917–922. 16 indexed citations
7.
Patel, Manesh R., et al.. (2018). Incidence and characteristics of major bleeding among rivaroxaban users with renal disease and nonvalvular atrial fibrillation. Clinical and Experimental Emergency Medicine. 5(1). 43–50.
8.
Malatestinic, William N., Beth Nordstrom, Jashin J. Wu, et al.. (2017). Characteristics and Medication Use of Psoriasis Patients Who May or May Not Qualify for Randomized Controlled Trials. Journal of Managed Care & Specialty Pharmacy. 23(3). 370–381. 16 indexed citations
9.
Peacock, W. Frank, et al.. (2016). CHA 2 DS 2 -VASc Scores and Major Bleeding in Patients With Nonvalvular Atrial Fibrillation Who Are Receiving Rivaroxaban. Annals of Emergency Medicine. 69(5). 541–550.e1. 9 indexed citations
10.
Peacock, W. Frank, et al.. (2016). Comparison of the Incidence of Major Bleeding With Rivaroxaban Use Among Nonvalvular Atrial Fibrillation Patients With Versus Without Diabetes Mellitus. The American Journal of Cardiology. 119(5). 753–759. 12 indexed citations
11.
Gallagher, Christopher, Tripthi Kamath, Anthony Masaquel, et al.. (2016). Delay in initiation of adjuvant trastuzumab therapy leads to decreased overall survival and relapse-free survival in patients with HER2-positive non-metastatic breast cancer. Breast Cancer Research and Treatment. 157(1). 145–156. 16 indexed citations
12.
Pullen, W. Michael, et al.. (2016). Predictors of Revision Surgery After Anterior Cruciate Ligament Reconstruction. The American Journal of Sports Medicine. 44(12). 3140–3145. 35 indexed citations
13.
Yeh, Wei‐Chang, et al.. (2015). The economic burden of Spinal Muscular Atrophy. Value in Health. 18(3). A282–A282. 1 indexed citations
14.
15.
Gaskill, Trevor R., et al.. (2015). The Prevalence of Symptomatic Deep Venous Thrombosis and Pulmonary Embolism After Anterior Cruciate Ligament Reconstruction. The American Journal of Sports Medicine. 43(11). 2714–2719. 51 indexed citations
16.
Peacock, W. Frank, Manesh R. Patel, Nicholas Sicignano, et al.. (2015). Characterizing Major Bleeding in Patients With Nonvalvular Atrial Fibrillation: A Pharmacovigilance Study of 27 467 Patients Taking Rivaroxaban. Clinical Cardiology. 38(2). 63–68. 127 indexed citations
17.
18.
Beydoun, Hind A., Nicholas Sicignano, May A. Beydoun, et al.. (2010). A cross-sectional evaluation of the first cohort of young adults conceived by in vitro fertilization in the United States. Fertility and Sterility. 94(6). 2043–2049. 49 indexed citations
19.
Sicignano, Nicholas, Hind A. Beydoun, Helena Russell, Howard Jones, & Sergio Oehninger. (2010). A descriptive study of asthma in young adults conceived by IVF. Reproductive BioMedicine Online. 21(6). 812–818. 16 indexed citations
20.
Beydoun, Hind A., Nicholas Sicignano, May A. Beydoun, et al.. (2010). Pubertal development of the first cohort of young adults conceived by in vitro fertilization in the United States. Fertility and Sterility. 95(2). 528–533. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nathalie Trillot Breakdown of academic impact, for papers by Chang Cl Breakdown of academic impact, for papers by Aditya Raju Breakdown of academic impact, for papers by Marie‐Hélène Horellou Breakdown of academic impact, for papers by Ioannis Karalis Breakdown of academic impact, for papers by IJ Mackie Breakdown of academic impact, for papers by Carsten Agger Breakdown of academic impact, for papers by J.-P. Cambou Breakdown of academic impact, for papers by Leslie Skeith Breakdown of academic impact, for papers by Zekeriya Nurkalem
Rankless by CCL
2026